I session. Chairs prof. M. Miglinas, dr. V. Banys |
10:00 – 10:30 | Prof. Alan Maisel, San Diego | Natriuretic peptides – history of implementation |
10:30 – 10:50 | Assoc. Prof. Dalius Vitkus, Vilnius | Laboratory tests of NPs and troponins – performance and differences |
10:50 – 11:20 | Prof. Theresa McDonagh, London | Natriuretic peptides in practice of family physician – effective healthcare technology? UK experience |
11:20 – 11:45 | Prof. Raimondas Kubilius, dr. Sonata Varvuolytė, Prof. Leonas Valius | Discussion: possibilities to apply the experience of using HF biomarkers in Lithuania, in practice of GPs and specialists |
Satellite lecture sponsored by Servier |
11:45 – 12:00 | Prof. Jelena Čelutkienė | How to achieve the goals of HF treatment more easily? |
Lunch |
II session. Chairs Dr. Nora Kupstytė-Krištaponė, Assoc. Prof. D. Karčiauskaitė |
13:00 – 13:25 | Prof. Alan Maisel, San Diego | Troponins and sST2 – tools for risk stratification |
13:25 – 13:55 | Prof. Alexandre Mebazaa, Paris | How biomarkers help to assess congestion? |
13:55 – 14:15 | Prof. Pranas Šerpytis, Assoc. Prof. Giedrė Bakšytė , Assoc. Prof. Jolanta Laukaitienė | Discussion: applying biomarkers for diagnosis and prognosis in acute HF setting |
Satellite lecture sponsored by Novartis |
14:15 – 14:30 | Assoc. Prof. Diana Žaliaduonytė | The newest choice for optimizing the treatment of HF patients |
Tea |
III session. Chairs prof. V. Kasiulevičius, prof. R. Šlapikas |
15:00 – 15:25 | Prof. Jelena Čelutkienė, Vilnius | Lithuanian national guidelines “Biomarkers for HF” |
15:25 – 15:45 | Assoc. Prof. Vytenis Kalibatas, Kaunas | Assessment of biomarker cost-effectiveness |
15:45 – 16:10 | Dr. Jose Morgado, Huelva | Do heart failure biomarkers create value in healthcare? Spain experience |
16:10 – 16:35 | NIF Adviser for Servise Expertise and Control Division Žydrūnė Baigienė | Cost of HF treatment – dynamics in recent years |
16:35 – 17:00 | Vice-Minister of Health of Lithuanian Republic, dr. Lina Jaruševičienė | HF care in Lithuania – challenges and solutions |